anti-CD19/BCMA CAR NK cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-CD19/BCMA CAR NK cell therapy, covering 2025-07-04 to 2025-07-04. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy [EARLY_Phase 1]